EGFR amplification has been associated with increased baseline ROS levels, and the dependence on DNA repair for cell survival, leading to increased sensitivity to a PARP inhibitor to halt double-strand break repair in patients with EGFRwt-overexpression GBM [30]. This evidence concerns the gene PARP1 and glioblastoma.